Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation

Virology Journal

Volumn 8, Issue , 2011, Pages

  Ahmad, Waqar ^a   Shabbiri, Khadija ^b   Ijaz, Bushra ^a   Asad, Sultan ^a   Sarwar, Muhammad T ^a   Gull, Sana ^a   Kausar, Humera ^a   Fouzia, Kiran ^b   Shahid, Imran ^a   Hassan, Sajida ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b GC UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR YY1; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHICKEN; GLYCOSYLATION; HEPATITIS C VIRUS; HUMAN; MALE; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RAT; SHEEP; SWINE; TIGHT JUNCTION; VIRUS ENTRY; XENOPUS; BIOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SEQUENCE ALIGNMENT;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; GLYCOSYLATION; HEPACIVIRUS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ALIGNMENT; VIRUS INTERNALIZATION;

EID: 79955876353     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-229     Document Type: Article

References (62)

1. Hepatitis C virus biology. C Giannini C Brechot, J Virol 2003 10 27 S38
2. Epidemiology of hepatitis C. MJ Alter, Hepatology 1997 26 62S 65S 10.1002/hep.510260711 9305666 (Pubitemid 27388074)
3. Hepatocellular carcinoma and hepatitis C in the United States. HB EL-Serag, Hepatology 2002 36 74 S83 12407579
4. The tight junction: A multifunctional complex. EE Schneeberger RD Lynch, Am J Physiol Cell Physiol 2004 286 1213 1228 10.1152/ajpcell.00558.2003 (Pubitemid 38649971)
5. Biology of Claudins. S Angelow R Ahlstrom AS Yu, Am J Physiol Renal Physiol 2008 295 867 876 10.1152/ajprenal.90264.2008
6. Hepatitis C virus entry into host cells. F Helle J Dubuisson, Cell Mol Life Sci 2008 65 100 112 10.1007/s00018-007-7291-8 17914604 (Pubitemid 351152228)
7. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. MJ Evans T von Hahn DM Tscherne AJ Syder M Panis B Wölk T Hatziioannou JA McKeating PD Bieniasz CM Rice, Nature 2007 446 801 8055 10.1038/nature05654 17325668
8. Claudins and epithelial paracellular transport. CM Van Itallie JM Anderson, Annu Rev Physiol 2006 68 403 429 10.1146/annurev.physiol.68.040104. 131404 16460278
9. Claudins upregulation in human colorectal cancer. SS Oliveira IM Oliveira W De Souza JA Morgado-Diaz, FEBS Lett 2005 579 6179 6185 10.1016/j.febslet. 2005.09.091 16253248 (Pubitemid 41546266)
10. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. CA Iacobuzio-Donahue A Maitra GL Shen-Ong T van Heek R Ashfaq R Meyer K Walter K Berg MA Hollingsworth JL Cameron CJ Yeo SE Kern M Goggins RH Hruban, Am J Pathol 2002 160 1239 1249 10.1016/S0002-9440(10)62551-5 11943709 (Pubitemid 34411628)
11. Gene expression in poorly differentiated papillary thyroid carcinomas. O Fluge O Bruland LA Akslen JR Lillehaug JE Varhaug, Thyroid 2006 16 161 175 10.1089/thy.2006.16.161 16676402
12. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. MB Resnick M Gavilanez E Newton T Konkin B Bhattacharya DE Britt E Sabo SF Moss, Hum Pathol 2005 36 886 892 10.1016/j.humpath.2005.05.019 16112005 (Pubitemid 41187907)
13. Claudin- based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. M Furuse M Hata K Furuse Y Yoshida A Haratake Y Sugitani T Noda A Kubo S Tsukita, J Cell Biol 2002 156 1099 1111 10.1083/jcb.200110122 11889141 (Pubitemid 34839858)
14. Proteomic analysis of post-translational modifications. M Mann ON Jensen, Nat Biotechnol 2003 21 255 261 10.1038/nbt0303-255 12610572 (Pubitemid 36314808)
15. Regulation of claudins by posttranslational modifications and cell signaling cascades. L Gonzalez-Mariscal E Garay M Quiros, Current Topics in Membranes 2010 65 113 150
16. Phosphorylation of Claudin-3 at Threonine 192 by cAMP-dependent Protein Kinase Regulates Tight Junction Barrier Function in Ovarian Cancer Cells. T D'Souza RPJ Agarwal, J Biol Chem 2005 280 26233 26240 10.1074/jbc.M502003200 15905176 (Pubitemid 41022220)
17. Phosphorylation of claudin-4 by pkc regulates tight junction barrier function in ovarian cancer Cells. T D'Souzaa FE Indigb PJ Morina, Exp Cell Res 2007 313 3364 3375 10.1016/j.yexcr.2007.06.026 17678893
18. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. AD French JL Fiori TC Camilli PD Leotlela MP O'Connell BP Frank S Subaran FE Indig DD Taub AT Weeraratna, Int J Med Sci 2009 6 93 101 19305641
19. Thr (207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. T Soma H Chiba Y Kato-Mori T Wada T Yamashita T Kojima N Sawada, Exp Cell Res 2004 300 202 212 10.1016/j.yexcr.2004.07.012 15383327 (Pubitemid 39286229)
20. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelia tight junction complex. V Nunbhakdi-Craig T Machleidt E Ogris D Bellotto CL White E Sontag, J Cell Biol 2002 158 967 978 10.1083/jcb.200206114 12196510 (Pubitemid 35001086)
21. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. K Kamemura BK Hayes FI Comer GW Hart, J Biol Chem 2002 277 19229 19235 10.1074/jbc.M201729200 11904304 (Pubitemid 34952491)
22. The emerging significance of O - GlcNAc in cellular regulation. NE Zachara GW Hart, Chem Rev 2002 102 431 438 10.1021/cr000406u 11841249 (Pubitemid 35377621)
23. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. B Boeckmann A Bairoch R Apweiler MC Blatter A Estreicher E Gasteiger MJ Martin K Michoud C O'Donovan I Phan S Pilbout M Schneider, Nucleic Acids Res 2003 31 365 370 10.1093/nar/gkg095 12520024 (Pubitemid 36157284)
24. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. SF AltschuL TL Madden AA Schaffer J Zhang Z Zhang W Miller DJ Lipman, Nucleic Acids Res 1997 25 3389 3402 10.1093/nar/25.17.3389 9254694 (Pubitemid 27359211)
25. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DJ Higgins TJ Gibson, Nucleic Acids Res 1994 22 4673 46780 http://www.ebi.ac.uk/Tools/msa/clustalw2/ 10.1093/nar/22.22.4673 7984417
26. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. N Blom S Gammeltoft S Brunak, J Mol Biol 1999 294 1351 1362 http://www.cbs.dtu.dk/services/NetPhos/ 10.1006/jmbi.1999.3310 10600390 (Pubitemid 30008805)
27. Intrinsic disorder and protein phosphorylation. LM Iakoucheva P Radivojac CJ Brown TR O'Connor JG Sikes Z Obradovic AK Dunker, Nucleic Acids Res 2004 32 1037 1049 http://www.ist.temple.edu/disphos/ 10.1093/nar/gkh253 14960716
28. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. N Blom T Sicheritz-Ponten R Gupta S Gammeltoft S Brunk, Proteomics 2004 4 1633 1649 http://cbs.dtu.dk/services/ NetPhosK 10.1002/pmic.200300771 15174133 (Pubitemid 38738322)
29. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. HD Huang TY Lee SW Tseng JT Horng, Nucleic Acids Res 2005 33 226 229 http://kinasephos.mbc.nctu.edu.tw/case2.html 10.1093/nar/gki471 (Pubitemid 44529913)
30. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. F Diella S Cameron C Gemund R Linding A Via B Kuster T Sicheritz-Ponten N Blom TJ Gibson, BMC Bioinformatics 2004 22 79 http://phospho.elm.eu.org
31. Prediction of glycosylation across the human proteome and the correlation to protein function. R Gupta S Brunak, Pac Sym Biocomput 2002 7 310 322 http://www.cbs.dtu.dk/services/YinOYang/
32. CREB in long-term potentiation in hippocampus: role of post-translational modifications-studies In silico. A Kaleem DC Hoessli IU Haq E Walker-Nasir A Butt Z Iqbal Z Zamani AR Shakoori Nasir-ud-Din, J Cell Biochem 2011 112 138 146 10.1002/jcb.22909 21053365
33. In silico modulation of HMGN-1 binding to histones and gene expression by interplay of phosphorylation and O - GlcNAc modification. I Ahmad TS Khan DC Hoessli E Walker-Nasir A Kaleem AR Shakoori Nasir-ud-Din, Protein Pept Lett 2008 15 193 199 18289110 (Pubitemid 351346472)
34. Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3. A Kaleem DC Hoessli I Ahmad E Walker-Nasir A Nasim AR Shakoori Nasir-ud-Din, J Cell Biochem 2008 103 835 851 10.1002/jcb.21454 17668447 (Pubitemid 351240619)
35. O-glycosylation Prediction Electronic Tool (OGPET): a new algorithm for prediction of O-glycosylation sites. R Torres IC Almeida, FASEB J 2006 20 1362 http://ogpet.utep.edu/OGPET/
36. UCSF Chimera - a visualization system for exploratory research and analysis. EF Pettersen TD Goddard CC Huang GS Couch DM Greenblatt EC Meng TE Ferrin, J Comput Chem 2004 25 1605 1612 http://zhanglab.ccmb.med.umich.edu/I- TASSER/ 10.1002/jcc.20084 15264254
37. I-TASSER server for protein 3D structure prediction. Y Zhang, BMC Bioinformatics 2008 9 40 10.1186/1471-2105-9-40 18215316
38. GRIS: Glycoprotein-hormone Receptor Information System. JV Durme F Horn S Costagliola G Vriend G Vassart, Molecular Endocrinology 2006 20 2247 2255 http://jmol.sourceforge.net/ 10.1210/me.2006-0020 16543405 (Pubitemid 44286717)
39. The PyMOL Molecular Graphics System. Schrödinger, LLC http://www.pymol.org/citing Version 1.3, http://www.pymol.org/export
40. A generic method for assignment of reliability scores applied to solvent accessibility predictions. B Petersen TN Petersen P Andersen M Nielsen C Lundegaard, BMC Structural Biology 2009 9 5 http://www.cbs.dtu.dk/services/ NetSurfP/ 10.1186/1472-6807-9-5 19183478
41. Bioinformatics: The machine learning Approach. P Baldi S Brunak, MIT Press. Cambridge, MA 2 2002
42. The claudins. M Lal-Nag PJ Morin, Genome Biol 2009 10 235 10.1186/gb-2009-10-8-235 19706201
43. New aspects of the molecular constituents of tissue barriers. HC Bauer A Traweger J Zweimueller-Mayer C Lehner H Tempfer I Krizbai I Wilhelm H Bauer, J Neural Transm 2011 118 7 21 10.1007/s00702-010-0484-6 20865434
44. The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. CM Van Itallie OR Colegio JM Anderson, J Membr Biol 2004 199 29 38 10.1007/s00232-004-0673-z 15366421 (Pubitemid 38766424)
45. Tight-junction protein zonula occludens 2 is a target of phosphorylation by protein kinase C. A Avila-Flores E Rendon-Huerta J Moreno S Islas A Betanzos M Robles-Flores L Gonzalez-Mariscal, Biochem J 2001 360 295 304 10.1042/0264-6021:3600295 11716757 (Pubitemid 33151324)
46. Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. M Fujibe H Chiba T Kojima T Soma T Wada T Yamashita N Sawada, Exp Cell Res 2004 295 36 47 10.1016/j.yexcr.2003.12.014 15051488 (Pubitemid 38407343)
47. theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. A Banan LJ Zhang M Shaikh JZ Fields S Choudhary CB Forsyth A Farhadi A Keshavarzian, J Pharmacol Exp Ther 2005 313 962 982 10.1124/jpet.105.083428 15900076 (Pubitemid 40727000)
48. Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells. HL Deissler H Deissler GE Lang, Invest Ophthalmol Vis Sci 2010 51 535 42 10.1167/iovs.09-3917 19643968
49. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. T Ishizaki H Chiba T Kojima M Fujibe T Soma H Miyajima K Nagasawa I Wada N Sawada, Exp Cell Res 2003 290 275 288 10.1016/S0014-4827(03)00354-9 14567987 (Pubitemid 37272172)
50. Thr (207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. T Soma H Chiba Y Kato-Mori T Wada T Yamashita T Kojima N Sawada, Exp Cell Res 2004 300 202 212 10.1016/j.yexcr.2004.07.012 15383327 (Pubitemid 39286229)
51. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. K Yamauchi T Rai K Kobayashi E Sohara T Suzuki T Itoh S Suda A Hayama S Sasaki S Uchida, Proc Natl Acad Sci USA 2004 101 4690 4694 10.1073/pnas.0306924101 15070779 (Pubitemid 38437472)
52. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. V Nunbhakdi-Craig T Machleidt E Ogris D Bellotto CL White E Sontag, J Cell Biol 2002 158 967 978 10.1083/jcb.200206114 12196510 (Pubitemid 35001086)
53. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. M Tanaka R Kamata R Sakai, J Biol Chem 2005 280 42375 42382 10.1074/jbc.M503786200 16236711 (Pubitemid 43023209)
54. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. SM Stamatovic OB Dimitrijevic RF Keep AV Andjelkovic, J Biol Chem 2006 281 8379 8388 10.1074/jbc.M513122200 16439355 (Pubitemid 43847939)
55. Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions. A Ikari S Matsumoto H Harada K Takagi H Hayashi Y Suzuki M Degawa M Miwa, J Cell Sci 2006 119 1781 1789 10.1242/jcs.02901 16608877 (Pubitemid 43811004)
56. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation. RS Haltiwanger S Busby K Grove S Li D Mason L Medina D Moloney G Philipsberg R Scartozzi, J Biochem Biophys Res Commun 1997 231 237 242 10.1006/bbrc.1997.6110 (Pubitemid 27214290)
57. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. KP Kearse GW Hart, Proc Natl Acad Sci 1991 88 1701 1705 10.1073/pnas.88.5.1701 2000378 (Pubitemid 21916293)
58. RNA polymerase II is a glycoprotein modification of the COOH-terminal domain by O-GlcNAc. WG Kelly ME Dahmus GW Hart, J Biol Chem 1993 268 10416 10426 8486697
59. Alternative O-glycosylation/Ophosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. X Cheng GW Hart, J Biol Chem 2000 276 10570 10575
60. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. CF Chou AJ Smith MB Omary, J Biol Chem 1992 267 3901 3906 1371281
61. Intracellular glycosylation and development. N O'Donnell, Biochim Biophys Acta 2002 1573 336 345 12417416 (Pubitemid 35335442)
62. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. FI Comer GW Hart, J Biol Chem 2000 275 38 29179 29182 10.1074/jbc.R000010200 10924527 (Pubitemid 32043784)